C&Y Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 42.1901 million yuan, an increase of 67.45%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, C&Y Pharmaceutical released its 2024 annual report, stating that the company's operating income was 847 million yuan, a year-on-year increase of 5.92%. The net profit attributable to shareholders of the listed company was 42.1901 million yuan, a year-on-year increase of 67.45%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.2287 million yuan. The basic earnings per share were 0.1746 yuan
According to the Zhitong Finance APP, C&Y Pharmaceutical (300254.SZ) released its annual report for 2024, reporting an operating income of 847 million yuan, a year-on-year increase of 5.92%. The net profit attributable to shareholders of the listed company was 42.1901 million yuan, a year-on-year increase of 67.45%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.2287 million yuan. The basic earnings per share were 0.1746 yuan